Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC [Phase 2]
This Phase 2 trial investigates neoadjuvant adebrelimab combined with chemoradiotherapy for resectable esophageal squamous cell carcinoma; t…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Study of XB002 in Subjects With Solid Tumors (JEWEL-101) [Phase 1]
JEWEL-101 is a Phase 1 trial of XB002 in patients with solid tumors, covering multiple indications. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors [Phase 2]
Phase 2 trial of ladiratuzumab vedotin in multiple advanced solid tumors was terminated, with results posted in March 2025.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating tislelizumab as a single-agent neoadjuvant immunotherapy for resectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of toripalimab combined with paclitaxel and cisplatin as neoadjuvant therapy for esophageal squamous cell carcinoma has been t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant Ivonescimab with chemotherapy for resectable esophageal squamous cell carcinoma; the study is not yet r…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab with or without ociperlimab in recurrent or metastatic esophageal squamous cell carcinoma has complete…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemoradiotherapy plus surgery versus surgery with adjuvant therapy for esophageal squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial comparing nal-iri/lv5-fu versus paclitaxel as second-line therapy for metastatic esophageal squamous cell carcinoma has comple…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC [NA]
An ongoing trial is evaluating neoadjuvant chemoradiotherapy combined with sequential perioperative PD-1 inhibition for locally advanced eso…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating second-line cabozantinib in combination with atezolizumab for recurrent or metastatic esophageal squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
This Phase 2 clinical trial evaluates penpulimab in combination with chemotherapy, with or without anlotinib, for patients with advanced eso…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence [Phase 2]
Phase 2 trial of adjuvant pembrolizumab for locally advanced esophageal squamous cell carcinoma at high risk of recurrence has completed and…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: A CR-UK Phase I Trial of LY3143921 [Phase 1]
Phase I trial update for LY3143921 sponsored by Cancer Research UK; the study is Active Not Recruiting and explores multiple cancer indicati…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer [Phase 2]
Phase 2 trial evaluating sintilimab as consolidation therapy after definitive concurrent chemoradiotherapy for locally advanced thoracic eso…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial is evaluating nimotuzumab in combination with sintilimab and chemotherapy for advanced esophageal squamous cell carcinoma an…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC [Phase 2]
This is a completed Phase 2 trial comparing Huachansu plus thoracic radiotherapy versus thoracic radiotherapy alone for Esophageal Squamous …
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma [NA]
A completed trial from Zhejiang Cancer Hospital evaluating different radiation doses in neoadjuvant chemoradiotherapy for resectable thoraci…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Clinical Trial of Esophagectomy for Esophageal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluated esophagectomy as treatment for esophageal squamous cell carcinoma and has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29) [Phase 2]
This Phase 2 trial (ACTS-29) evaluating preoperative chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC [Phase 2]
Phase 2 trial evaluating sintilimab plus chemotherapy followed by definitive chemoradiotherapy in locally advanced esophageal squamous cell …
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing Simmitinib to chemotherapy for advanced esophageal squamous cell carcinoma is not yet recruiting. Sponsor: Shanghai …
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma [Phase 2]
Phase 2 trial evaluating BGB-A317 in combination with chemotherapy as first-line treatment for adults with inoperable, locally advanced, or …
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating local therapy for oligorecurrent and oligometastatic esophageal squamous cell carcinoma; status is complet…